跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle
Approved
STANDARD
INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle
Taiho Pharma Oceania Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
f18999efe1bbbedf
Company
Taiho Pharma Oceania Pty Ltd
Type
Standard
Approval Details
Approval Id
f18999efe1bbbedf
Product Name
INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle
Artg Id
328904
Artg Name
INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle
Sponsor
Taiho Pharma Oceania Pty Ltd
Company Detail Path
/organization/taiho-pharma-oceania-pty-ltd
Artg Date
2020-11-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b8d9b62dc2f52e53ada58e3da7a481c9.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/57bbf60760ce58762e28e49bc1585263.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
f18999efe1bbbedf
Type
Standard
Back to TGA Approvals